Literature DB >> 20110906

Synthesis of some new mono- and bis-polycyclic aromatic spiro and bis-nonspiro-beta-lactams.

Aliasghar Jarrahpour1, Edris Ebrahimi.   

Abstract

Some new mono-and bis-polycyclic aromatic spiro-beta-lactams and n class="Chemical">bis-non spiro-polycyclic aromatic beta-lactams have been synthesized from imines derived from anthracene-9-carbaldehyde, 2-naphtaldehyde and a ketene derived from 9H-xanthene-9-carboxylic acid and phenoxyacetic acid by a [2+2] cycloaddition reaction. The cycloadducts were characterized by spectral data, including 1H-NMR, 13C-NMR, IR and elemental analyses. The configurations of some of these mono-spiro-beta-lactams were established by X-ray crystal analysis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20110906      PMCID: PMC6256923          DOI: 10.3390/molecules15010515

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

β-Lactams, being a structural unit found in the most widely used antibiotics [1], have occupied a basic position in medicinal chemistry for almost a century now. With the microbes responding to the traditional antibiotics through β-lactamases, the need for novel antibiotics prevails, making synthesis of newer β-lactams ever more important. In addition to their use as antibiotics, β-lactams are increasingly being used as n class="Chemical">synthons for other biologically important molecules [2,3,4,5,6,7,8,9,10,11]. β-Lactams have been found to act as cholesterol acyl transferase inhibitors [12], thrombin inhibitors [13], human cytomegalovirus protease inhibitors [14], matrix metalloprotease inhibitors [15], cysteine protease [16], and apoptosis inductors [17]. Spirocyclic β-lactams have attracted attention as they have been shown to be β-turn mimetics [18,19] and precursors for α,α-disubstituted β-amino acids [20]. The chartelline has a spiro-β-lactam moiety in its structure marine natural products [21]. It has been found that spiro-β-lactams act as poliovirus and human rhinovirus 3C-proteinases inhibitors [22]. These compounds are mostly synthesized by cycloaddition to an exocyclic bond. Several syntheses of spiro-β-lactams have been reported [23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42]. Polycyclic aromatic β-lactams have shown anticancer and other biological activities [43,44,45]. Some polyaromatic β-lactams have been reported to have polyaromatic ring in part of imines that prepared by Staudinger reaction [46]. Therefore in continuation of our work on the synthesis of novel β-lactams [47,48,49], we present here for the first time the results obtained in the synthesis of mono- and bis-polyaromatic spiro and nonspiro-β-lactams using a modified Staudinger reaction.

2. Results and Discussion

Treatment of anthracene-9-carbaldehyde or n class="Chemical">2-naphtaldehyde with different primary amines in refluxing ethanol afforded the polycyclic aromatic imines 1a–n [50,51,52,53]. These Schiff bases were then treated with 9H-xanthene-9-carboxylic acid in the presence of triethylamine and tosyl chloride to afford polycyclic aromatic spiro-β-lactams 2a–n as single diastereomers (Scheme 1). The reaction progress was monitored by TLC and the presence of a new compound was confirmed. In addition, the cycloadducts were characterized by spectral analysis. For 2a the IR spectrum showed the characteristic absorption of a β-lactam carbonyl at 1,747 cm−1. The 1H-NMR spectrum exhibited the methoxy protons as a singlet at 3.64 ppm, the β-lactam H-4 proton as a singlet at 6.29 and aromatic protons as a multiplet at 6.39–8.82. The 13C-NMR spectrum exhibited the C-3 (spiro carbon) at 64.3. The results for other polycyclic aromatic spiro-β-lactams 2a–n are shown in Table 1.
Scheme 1

Synthesis of polycyclic aromatic spiro-β-lactams 2a–n.

Table 1

Structures of spiro-β-lactams.

EntryProductYield (%) aEntryProductYield (%) a
12a2562f40
22b5472g35
32c5182h53
42d6392i70
52e70102j91
112k69132m50
122l68142n40

a Isolated yield of pure products.

Then we decided to synthesize bis-spiro- and bis-nonspiro- n class="Chemical">polycyclic aromatic β-lactams 4a–d, 6b and 4e–h, 6a from bis-imines 3a–d and 5 [53] (Scheme 2). The structures of 4a–h and 5a–b are shown in Table 2. The cis-trans stereochemistry of 2-azetidinones 4e–h and 6a were deduced from the coupling constant of H-3 and H-4, which was calculated to be J3,4 = 4–9 Hz for the cis and J3,4 = 1–3 Hz for the trans stereoisomers.
Scheme 2

Synthesis of bis-spiro- and bis-nonspiro- polycyclic aromatic β-lactams 4a–h and 6a–b.

Table 2

Structures of bis-spiro and bis-nonspiro-β-lactams.

EntryProductYield(%)aEntryProductYield(%)a
14a9264f87
24b8774g90
34c9684h95
44d8596a96
54e80106b85

a Isolated yields of pure products.

The X-ray crystallography of 2a (Figure 1) confirmed the proposed spiro configuration at C3 [54,55,56,57,58,59]. The X-ray analysis also showed that the β-lactam ring is planar and it is perpendiculn class="Chemical">ar to xanthene ring. The anthracene ring has dihedral angles of 51.8° with the β-lactam ring.
Figure 1

X-ray crystal structure of 2a.

3. Experimental Section

3.1. General

All needed chemicals were purchased from the Merck, Fluka or Acros chemical companies. All reagents and solvents were dried prior to use according to standard methods [60]. IR spectra were run on a Shimadzu FT-IR 8300 spectrophotometer. n class="Chemical">1H-NMR and 13C-NMR spectra were recorded in DMSO-d6 or CDCl3 using a Bruker Avance DPX instrument (1H-NMR 250 MHz, 13C-NMR 62.9 MHz). Chemical shifts were reported in parts per million (δ) downfield from TMS. All of the coupling constants (J) are in hertz. The mass spectra were recorded on a Shimadzu GC-MS QP 1000 EX instrument. Elemental analyses were run on a Thermo Finnigan Flash EA-1112 series. Melting points were determined in open capillaries with Buchi 510 melting point apparatus. Thin-layer chromatography was carried out on silica gel F254 analytical sheets obtained from Fluka. Column chromatography was performed on Merck Kiesel gel (230–270 mesh).

3.2. General Procedure for Preparation of Schiff Bases

A mixture of an aromatic amine (1.00 mmol) and n class="Chemical">anthracene-9-carbaldehyde or 2-naphtaldehyde (1.00 mmol) was refluxed in ethanol (20 mL) for 1–5 hours. After cooling, the pure Schiff bases were separated as crystals. Some of these were recrystallized from ethanol. (E)-N-(Anthracen-10-ylmethlene)-4-methxybenzenamine (1a): Yellow powder crystal (yield 91%); Mp: 140–148 °C; IR (n class="Chemical">CHCl3, cm−1): 1,608 (C=N); 1H-NMR δ (ppm): 3.88 (OMe, s, 3H), 6.52–7.64 (ArH, m, 13H), 9.80 (CHN, s, 1H). Analysis calculated for C22H17NO: C, 84.86; H, 5.50; N, 4.50%. Found: C, 84.83; H, 5.55; N, 4.48%. (E)-N-(Anthracen-10-ylmethylene)-3-methoxybenzenamine (1b): Yellow powder crystal (yield 84%); Mp: 100–102 °C; IR (n class="Chemical">CHCl3, cm−1): 1,608 (C=N); 1H-NMR δ (ppm): 3.87 (OMe, s, 3H), 6.89–8.74 (ArH, m, 13H), 9.66 (CHN, s, 1H). Analysis calculated for C22H17NO: C, 84.86; H, 5.50; N, 4.50%. Found: C, 84.83; H, 5.55; N, 4.48%. (E)-N-(Anthracen-10-ylmethylene)-2-methoxybenzenamine (1c): Orange powder crystal (yield 76%); Mp: 94–96 °C; IR (n class="Chemical">CHCl3, cm−1): 1,620 (C=N); 1H-NMR δ (ppm): 6.73–8.75 (ArH, m, 13H), 9.66 (CHN, s, 1H). Analysis calculated for C22H17NO: C, 84.86; H, 5.50; N, 4.50%. Found: C, 84.83; H, 5.55; N, 4.48%. (E)-N-(Anthracen-10-ylmethylene)benzenamine (1d): Yellow powder crystal (yield 76%); Mp: 102–104 °C; IR (KBr, cm−1): 1,608 (C=N); n class="Chemical">1H-NMR δ (ppm): 6.61–8.96 (ArH, m, 14H), 9.63 (CHN, s, 1H). Analysis calculated for C21H15N: C, 89.65; H, 5.37; N, 4.98%. Found: C, 89.61; H, 5.41; N, 4.95%. (E)-N-(Anthracen-10-ylmethylene)-4-chlorobenzenamine (1e): Yllow crystal (yield 51%); Mp: 182–184 °C; IR (KBr, cm−1): 1,623 (C=N); n class="Chemical">1H-NMR δ (ppm): 6.64–8.72 (ArH, m, 13H), 9.61 (CHN, s, 1H). Analysis calculated for C21H14ClN: C, 79.87; H, 4.47; N, 4.44%. Found: C, 79.85; H, 4.50; N, 4.49%. (E)-N-(Anthracen-10-ylmethylene)-3-nitrobenzenamine (1f): Orange crystal (yield 67%); Mp: 166–168 °C; IR (KBr, cm−1): 1,666 (C=N); n class="Chemical">1H-NMR δ (ppm): 6.62–8.96 (ArH, m, 13H), 9.66 (CHN, s, 1H). Analysis calculated for C21H14N2O2: C, 77.29; H, 4.32; N, 8.58%. Found: C, 77.35; H, 4.38; N, 8.60%. (E)-N-(Anthracen-10-ylmethylene)-2-ethylbenzenamine (1g): Yellow crystal (yield 60%); Mp: 182–184 °C; IR (CHCl3, cm−1): 1,620 (C=N); n class="Chemical">1H-NMR δ (ppm): 1.27 (CH2, t, 2H, J = 7.5), 2.89 (CH3, q, 4H, J = 7.5), 6.82–8.80 (ArH, m, 13H), 9.55 (CHN, s, 1H). Analysis calculated for C23H19N: C, 89.28; H, 6.19; N, 4.53%. Found: C, 89.32; H, 6.25; N, 4.55%. (E)-N-(Anthracen-10-ylmethylene)-3-bromobenzenamine (n class="Chemical">1h): Yellow crystal (yield 77%); Mp: 122–124 °C; IR (KBr, cm−1): 1,620 (C=N); 1H-NMR δ (ppm): 6.84–8.71 (ArH, m, 13H), 9.60 (CHN, s, 1H). Analysis calculated for C21H14BrN: C, 70.01; H, 3.92; N, 3.89%. Found: C, 70.11; H, 3.98; N, 3.84%. (E)-N-(Anthracen-10-ylmethylene)-2,4-dimethoxybenzenamine (1i): Orange crystal (yield 88%); Mp: 160–162 °C; IR (CHCl3, cm−1): 1,616 (C=N); n class="Chemical">1H-NMR δ (ppm): 3.75, 3.98 (2OMe, s, 6H), 6.51–8.73 (ArH, m, 12H), 9.92 (CHN, s, 1H). Analysis calculated for C23H19NO2: C, 80.92; H, 5.61; N, 4.10%. Found: C, 80.96; H, 5.66; N, 4.17%. (E)-N-(Anthracen-10-ylmethylene)-3,4-dimethoxybenzenamine (1j): Orange crystal (yield 90%); Mp: 160–162 °C; IR (CHCl3, cm−1): 1,605 (C=N); n class="Chemical">1H-NMR δ (ppm): 3.88, 3.91 (2OMe, s, 6H), 6.88–8.68 (ArH, m, 12H), 9.92 (CHN, s, 1H). Analysis calculated for C23H19NO2: C, 80.92; H, 5.61; N, 4.10%. Found: C, 80.96; H, 5.66; N, 4.17%. (E)-N-(Anthracen-10-ylmethylene)cyclohexanamine (1k): Orange crystal (yield 92%); Mp: 132–134 °C; IR (CHCl3, cm−1): 1,639 (C=N); n class="Chemical">1H-NMR δ (ppm): 1.34–3.56 (cyclohexyl, m, 11H), 7.41–8.43 (ArH, m, 9H), 9.34 (CHN, s, 1H). Analysis calculated for C21H21N: C, 87.76; H, 7.36; N, 4.87%. Found: C, 87.71; H, 7.33; N, 4.91%. (E)-N-(Anthracen-10-ylmethlene)naphthalene-1-amine (1l): Yellow crystal (yield 60%); Mp: 142–144° C; IR (n class="Chemical">CHCl3, cm−1): 1,624 (C=N); 1H–NMR δ (ppm): 6.67–8.94 (Ar-H, m, 16H), 8.80 (CHN, s, 1H). Analysis calculated for C25H17N: C, 90.60; H, 5.17; N, 4.23%. Found: C, 90.66; H, 5.20; N, 4.28%. (E)-N-(Naphthalen-2-ylmethylene)naphthalen-1-amine (1m): Green crystal (yield 78%); Mp: 129–130° C. IR (n class="Chemical">CHCl3, cm−1): 1,624 (C=N); 1H–NMR δ (ppm): 6.73–8.63 (Ar-H, m, 14H), 8.94 (CHN, s, 1H). Analysis calculated for C25H17N: C, 90.60; H, 5.17; N, 4.23%. Found: C, 90.66; H, 5.20; N, 4.28%. (E)-4-Methoxy-N-(naphthalen-2-ylmethylene)benzenamine (1n): Silver powder crystal (yield 80%); Mp: 118–120° C; IR (n class="Chemical">CHCl3, cm−1): 1,620 (C=N); 1H-NMR δ (ppm): 3.78 (OMe, s, 3H), 6.90–8.13 (ArH, m, 11H), 8.60 (CHN, s, 1H). Analysis calculated for C18H15NO: C, 82.73; H, 5.79; N, 5.36%. Found: C, 82.75; H, 5.83; N, 5.32%.

3.3. General Procedure for Preparation of Bis-Schiff Bases and

A mixture of anthracene-9-carbaldehyde (1.00 mmol) and n class="Chemical">bisamine (0.50 mmol) was refluxed in ethanol (20 mL) for (1–5) h. After cooling, the pure Schiff bases were separated as crystals. Some of these were recrystallized from ethanol. (E)-4-(E)-4-[(E)-Anthracen-10-ylmethyleneamino)benzyl]-N-(anthracen-10-ylmethylene)benzene-amine (3a): Yellow powder (yield 96%); Mp: 216–218 °C; IR (KBr, cm−1): 1,623 (C=N); n class="Chemical">1H-NMR δ (ppm): 4.15 (CH2, s, 2H), 6.68–9.70 (ArH, m, 26H), 10.02 (CH=N, s, 2H); Analysis calculated for C43H30N2: C, 89.86; H, 5.26; N, 4.87%. Found: C, 89.81; H, 5.22; N, 4.83%. (E)-3-(E)-3-[(E)-Anthracen-10-ylmethyleneamino)benzyl]-N-(anthracen-10-yl-methylene)benzenenamine (3b): Yellow powder (yield 95%); Mp: 184–186 °C; IR (KBr, cm−1): 1,623 (C=N); 1H-NMR δ (ppm): 4.19 (CH2, s, n class="Chemical">2H), 7.24–8.92 (ArH, m, 26H), 9.73 (CH=N, s, 2H); Analysis calculated for C43H30N2: C, 89.86; H, 5.26; N, 4.87%. Found: C, 89.81; H, 5.22; N, 4.83%. (E)-N-(Anthracen-10-yl-methylene)-4-(4-[(E)-anthracen-10-ylmethyleneamino]phenoxy)benzene-amine (3c): Orange powder (yield 96%); Mp: 202–204 °C; IR (KBr, cm−1): 1,608 (C=N); 1H-NMR δ (ppm): 6.73–8.78 (n class="Chemical">ArH, m, 26H), 9.60 (CH=N, s, 2H); Analysis calculated for C42H28N2O: C, 87.47; H, 4.89; N, 4.86%. Found: C, 87.51; H, 4.95; N, 4.81%. (E)-N-(Anthracen-10-ylmethylene)-3-(4-[(E)-anthracen-10-ylmethyleneamino]phenoxy)benzeneamine (3d): Yellow powder (yield 88%); Mp: 216–218 °C; IR (KBr, cm−1): 1,620 (C=N); 1H-NMR δ (ppm): 6.20–9.01 (n class="Chemical">ArH, m, 26H), 9.71 (CH=N, s, 2H); Analysis calculated for C42H28N2O: C, 87.47; H, 4.89; N, 4.86%. Found: C, 87.51; H, 4.95; N, 4.81%. (N (5): Yellow powder (yield 95%); Mp: > 240 °C; IR (KBr, cm−1): 1,604 (C=N); 1H-NMR δ (ppm): 7.25–8.84 (n class="Chemical">ArH, m, 22H), 9.81 (CHN, s, 2H). Analysis calculated for C36H24N2: C, 89.23; H, 4.99; N, 5.78%. Found: C, 89.28; H, 5.05; N, 5.73%.

3.4. General Procedure for the Synthesis of Polycyclic Aromatic Spiro-β-Lactams

A mixture of Schiff base (1.00 mmol), n class="Chemical">triethylamine (5.00 mmol), 9H-xanthene-9-carboxylic acid (1.50 mmol) and tosyl chloride (1.50 mmol) in dry CH2Cl2 (15 mL) was stirred at room temperature for 24 h. Then it was washed with HCl 1N (20 mL), saturated NaHCO3 (20 mL) and brine (20 mL). The organic layer was dried (Na2SO4), filtered and the solvent was evaporated to give the product as a crystal which was then purified by recrystallization from appropriate organic solvents. 2-(Anthracen-9-yl)-1-(4-methoxyphenyl)spiro[azetidine-3,9’-xanthen]-4-one (2a): Light yellow crystals from EtOAc (yield 25%); Mp: 223–225 °C; IR (CHCl3, cm−1): 1,740 (CO β-lactam); n class="Chemical">1H-NMR δ (ppm): 3.64 (OMe, s, 3H) 6.29 (H-4, s, 1H), 6.51–8.82 (ArH, m, 21H); 13C-NMR δ (ppm) 64.3 (OMe) 82.8 (C-3), 75.6 (C-4), 116.4–152.2 (aromatic carbon), 167.3 (CO β-lactam); GC-MS m/z = 519 [M+]; Analysis calculated for C36H25NO3: C, 83.22; H, 4.85; N, 2.70%. Found: C, 83.95; H, 4.90; N, 2.82. 2-(Anthracen-9-yl)-1-(3-methoxyphenyl)spiro[azetidine-3,9’-xanthen]-4-one (2b): Yellow crystals from EtOAc (yield 54%); Mp: 212–214 °C; IR (CHCl3, cm−1): 1,755 (CO β-lactam); n class="Chemical">1H-NMR δ (ppm): 3.75 (OMe, s, 3H) 6.33 (H-4, s, 1H), 6.53–8.80 (ArH, m, 21H); 13C-NMR δ (ppm): 55.3 (OMe) 65.6 (C-3), 75.6 (C-4), 103.5–160.4 (aromatic carbon), 167.6 (CO β-lactam); GC-MS m/z = 519 [M+]; Analysis calculated for C36H25NO3: C, 83.22; H, 4.85; N, 2.70%. Found: C, 83.95; H, 4.90; N, 2.82%. 2-(Anthracen-9-yl)-1-(2-methoxyphenyl)spiro[azetidine-3,9’-xanthen]-4-one (2c): Light yellow crystals from EtOAc (yield 57%); Mp: 214–216 °C (dec.); IR (KBr, cm−1): 1,739 (CO β-lactam); 1H-NMR δ (ppm): 2.94 (OMe, s, n class="Chemical">3H), 6.34 (H-4, s, 1H), 6.55–9.20 (ArH, m, 21H);13C-NMR δ (ppm): 55.4 (OMe), 66.0 (C-3), 78.5 (C-4), 112.8–152.0 (aromatic carbon), 168.0 (CO β-lactam); GC-MS m/z = 519 [M+]; Analysis calculated for C36H25NO3: C, 83.22: H, 4.85; N, 2.70%. Found: C, 83.90; H, 4.80; N, 2.81%. 2-(Anthracen-9-yl)-1-phenylspiro[azetidine-3,9’-xanthen]-4-one (2d): Light yellow crystals from EtOAc (yield 63%); Mp: 238–240 °C (dec.); IR (KBr, cm−1): 1,758 (CO β-lactam); 1H-NMR δ (ppm): 6.34 (H-4, s, n class="Chemical">1H), 6.51–8.83 (ArH, m, 22H); 13C-NMR δ (ppm): 65.6 (C-3), 75.4 (C-4), 115.9–152.0 (aromatic carbon), 167.5 (CO β-lactam); GC-MS m/z = 489 [M+]; Analysis calculated for C35H23NO2: C, 85.87; H, 4.74; N, 2.86%. Found: C, 85.87; H, 4.74; N 2.86%. 2-(Anthracen-9-yl)-1-(4-chlorophenyl)spiro[azetidine-3,9’-xanthen]-4-one (2e): Yellow crystals from EtOAc (yield 70%); Mp: 254–256 °C (dec.); IR (KBr, cm−1): 1,743 (CO β-lactam); 1H-NMR δ (ppm): 6.30 (H-4, s, n class="Chemical">1H), 6.52–9.06 (ArH, m, 21H); 13C-NMR δ (ppm): 66.0 (C-3), 75.5 (C-4), 116.0–151.9 (aromatic carbon), 167.4 (CO β-lactam); GC-MS m/z = 524 [M+, 35Cl], 526 [M+, 37Cl]; Analysis calculated for C35H22ClNO2: C, 80.22; H, 4.23; N 2.67%. Found: C, 80.28; H, 4.18; N, 2.53%. 2-(Anthracen-9-yl)-1-(3-nitrophenyl)spiro[azetidine-3,9’-xanthen]-4-one (2f): Yellow crystals from EtOAc (yield 40%); Mp: 212–214 °C; IR (KBr, cm−1): 1,762 (CO β-lactam); 1H-NMR δ (ppm): 5.98 (H-4, s, n class="Chemical">1H), 6.40–9.16 (ArH, m, 21H); 13C-NMR δ (ppm): 66.4 (C-3), 75.8 (C-4), 112.4–152.1 (aromatic carbon), 169.2 (CO β-lactam); GC-MS m/z = 534 [M+]; Analysis calculated for C35H22N2O4: C, 78.64; H, 4.15; N, 5.24%. Found: C, 78.63; H, 4.20; N, 5.32%. 2-(Anthracen-9-yl)-1-(2-ethylphenyl)spiro[azetidine-3,9’-xanthen]-4-one (2g): White solid (yield 35%); Mp: 208–210 °C; IR (KBr, cm−1): 1,755 (CO β-lactam); 1H-NMR δ (ppm): 1.14 (t, n class="Chemical">3H, Me, J = 7.1), 4.00 (CH2, q, 2H, J = 7.1), 4.92 (s, 1H, H-4), 6.30–8.74 (ArH, m, 21H); 13C-NMR δ (ppm): 15.1 (CH3), 25.8 (CH2), 64.5 (C-3), 75.1 (C-4), 115.9–152.2 (aromatic carbon), 168.1 (CO β-lactam); GC-MS m/z = 517 [M+]; Analysis calculated for C37H27NO2: C, 85.85; H, 5.26; N, 2.71%. Found: C, 85.83; H, 5.30; N, 2.76%. 2-(Anthracen-9-yl)-1-(3-bromophenyl)spiro[azetidine-3,9’-xanthen]-4-one (2h): Yellow crystals from EtOAc (yield 55%); Mp: 222–224 °C; IR (KBr, cm−1): 1,755 (CO β-lactam); n class="Chemical">1H-NMR δ (ppm): 6.18 (H-4, s, 1H), 6.23–8.65 (ArH, m, 21H); 13C-NMR δ (ppm): 66.0 (C-3), 75.6 (C-4), 115.7–151.9 (aromatic carbon), 167.7 (CO β-lactam); GC-MS m/z = 567 [M+, 80Br], 569 [M+, 82Br]; Analysis calculated for C35H22BrNO2: C, 73.95; H, 3.90; N, 2.46%. Found: C, 73.90; H, 3.93; N, 2.51%. 2-(Anthracen-9-yl)-1-(2,4-dimethoxyphenyl)spiro[azetidine-3,9’-xanthen]-4-one (2i): Light green crystals from EtOAc (yield 69%); Mp: 180–182 °C (dec.); IR (KBr, cm−1): 1,739 (CO β-lactam); 1H-NMR δ (ppm): 2.91, 3.58 (2OMe, s, 6H) 6.16 (H-4, s, n class="Chemical">1H), 6.17–8.18 (ArH, m, 20H); 13C-NMR δ (ppm): 55.4, 55.5 (s, 6H, 2 OMe) 65.9 (C-3), 78.1 (C-4), 100.2–158.2 (aromatic carbon), 167.7 (CO β-lactam); GC-MS m/z = 549 [M+]; Analysis calculated for C37H27NO4: C, 80.86; H, 4.95; N, 2.55%. Found: C, 80.03; H, 4.98; N, 2.83%. 2-(Anthracen-9-yl)-1-(3,4-dimethoxyphenyl)spiro[azetidine-3,9’-xanthen]-4-one (2j): Yellow solid (yield 91%); Mp: 172–174 °C; IR (KBr, cm−1): 1,743 (CO β-lactam); 1H-NMR δ (ppm): 3.69, 3.97 (2OMe, s, 6H) 6.30 (H-4, s, n class="Chemical">1H), 6.50–8.77 (ArH, m, 20H); 13C-NMR δ (ppm): 55.9, 56.1 (2 OMe) 65.6 (C-3), 75.6 (C-4), 102.3–153.0 (aromatic carbon), 166.9 (CO β-lactam); GC-MS m/z = 549 [M+]; Analysis calculated for C37H27NO4: C, 80.86; H, 4.95; N, 2.55%. Found: C, 80.81; H, 4.97; N, 2.53%. 2-(Anthracen-9-yl)-1-cyclohexylspiro[azetidine-3,9’-xanthen]-4-one (2k): Orange crystals from EtOAc (yield 69%); Mp: 216–218 °C; IR (KBr, cm−1): 1,743 (CO β-lactam); 1H-NMR δ (ppm): 1.53, 1.75, 1.95, 2.22, 2.65, 3.81 (cyclohexyl, m, n class="Chemical">11H) 5.96 (H-4, s, 1H), 6.36–9.19 (ArH, m, 17H); 13C-NMR δ (ppm): 24.5, 25.5, 30.0, 31.0, 56.7 (cyclohexyl) 64.5 (C-3), 72.8 (C-4), 115.9–152.4 (aromatic carbon), 169.6 (CO β-lactam); GC-MS m/z = 495 [M+]; Analysis calculated for C35H29NO2: C, 84.82; H, 5.90; N, 2.83%. Found: C, 84.81; H, 5.92; N, 2.81%. 2-(Anthracen-9-yl)-1-(naphthalen-1-yl)spiro[azetidine-3,9’-xanthen]-4-one (2l): Orange crystals from EtOAc (yield 68%); Mp: 184–186 °C (dec.); IR (CHCl3, cm−1): 1,759 (CO β-lactam); n class="Chemical">1H-NMR δ (ppm): 6.45 (H-4, s, 1H), 6.61–9.8 (ArH, m, 24H); 13C-NMR δ (ppme) 90.3 (C-3), 74.8 (C-4), 116.7–152.1 (aromatic carbon), 168.3 (CO β-lactam); GC-MS m/z = 539 [M+]; Analysis calculated for C39H25NO2: C, 86.80; H, 4.67; N, 2.60%. Found: C, 86.52; H, 4.63; N, 2.61%. 1-(Naphthalen-1-yl)-2-(naphthalen-2-yl)spiro[azetidine-3,9’-xanthen]-4-one (2m): White solid (yield 50%); Mp: 187–189 °C; IR (KBr, cm−1): 1,758 (CO β-lactam); 1H-NMR δ (ppm) 5.73 (H-4, s, n class="Chemical">1H), 6.50–9.00 (ArH, m, 22H); 13C-NMR δ (ppm): 62.8 (C-3), 75.8 (C-4), 116.4–152.29 (aromatic carbon), 196.3 (CO β-lactam); GC-MS m/z = 489 [M+]; Analysis calculated for C35H23NO2: C, 85.87; H, 4.74; N, 2.86%. Found: C, 85.67; H, 4.65; N, 2.79%. 1-(4-Methoxyphenyl)-2-(naphthalen-2-yl)spiro[azetidine-3,9’-xanthen]-4-one (2n): Gray solid (yield 40%); Mp: 184–186 °C; IR (CHCl3, cm−1): 1,751 (CO β-lactam); n class="Chemical">1H-NMR δ (ppm): 3.81 (OMe, s, 3H) 5.21 (H-4, s, 1H), 6.64–8.33 (ArH, m, 19H); 13C-NMR δ (ppm): 55.5 (OMe) 64.0 (C-3), 74.6 (C-4), 113.9–151.8 (aromatic carbon), 167.0 (CO β-lactam); GC-MS m/z = 469 [M+]; Analysis calculated for C32H23NO3: C, 81.86; H, 4.94; N, 2.98%. Found: C, 81.53; H, 4.98; N, 2.83%.

3.5. General Procedure for the Synthesis of Bis-Polycyclic Aromatic Spiro and Nonspiro-β-Lactams and

A mixture of Schiff base (1.00 mmol), n class="Chemical">triethylamine (10.00 mmol), 9H-xanthen-9-carboxylic acid or phenoxyacetic acid (3.00 mmol) and tosyl chloride (3.00 mmol) in dry CH2Cl2 (15 mL) was stirred at room temperature for 24 h. Then it was washed with HCl 1N (20 mL), saturated NaHCO3 (20 mL) and brine (20 mL). The organic layer was dried (Na2SO4), filtered and the solvent was evaporated to give the product as a crystal which was then purified by recrystallization from suitable organic solvents. 2-(Anthracen-9-yl)-1-(4-(4-(2-(anthracen-9-yl)-4-oxospiro[azetidine-3,9’-xanthene]-1-yl)benzyl)-phenyl)spiro[azetidine-3,9’-xanthen]-4-one (4a): Orange solid (yield 92%); Mp: 162–164 °C (dec.); IR (KBr, cm−1): 1,755 (CO β-lactam); n class="Chemical">1H-NMR δ (ppm): 3.76 (CH2, s, 2H) 6.15 (H-4, s, 2H), 6.19–8.99 (ArH, m, 42H); 13C-NMR δ (ppm): 40.8 (CH2) 65.7 (C-3), 75.4 (C-4), 115.9–152.0 (aromatic carbon), 167.3 (CO β-lactam). Analysis calculated for C71H46N2O4: C, 86.04; H, 4.68; N, 2.83%. Found: C, 86.10; H, 4.71; N, 2.80%. 2-(Anthracen-9-yl)-1-(3-(3-(2-(anthracen-9-yl)-4-oxospiro[azetidine-3,9’-xanthene]-1-yl)benzyl) phenyl)spiro[azetidine-3,9’-xanthen]-4-one (4b): Orange solid (Yield 87%); Mp: 220–222 °C (dec.); IR (KBr, cm−1): 1,758 (CO β-lactam); n class="Chemical">1H-NMR δ (ppm): 3.78 (CH2, s, 2H,) 6.22 (H-4, s, 2H), 6.26–9.52 (ArH, m, 42H); 13C-NMR δ (ppm): 41.5 (CH2) 59.6 (C-3), 75.4 (C-4), 115.9–152.0 (aromatic carbon), 167.4 (CO β-lactam). Analysis calculated for C71H46N2O4: C, 86.04; H, 4.68; N, 2.83%. Found: C, 86.06; H, 4.70; N, 2.80%. 2-(Anthracen-9-yl)-1-(4-(4-(2-(anthracen-9-yl)-4-oxospiro[azetidine-3,9’-xanthene]-1-yl)phenoxy) phenyl)spiro[azetidine-3,9’-xanthen]-4-one (4c): Yellow solid (Yield 75%); Mp: 242–244 °C (dec.); IR (KBr, cm−1): 1,755 (CO β-lactam); n class="Chemical">1H-NMR δ (ppm): 6.20 (H-4, s, 2H), 6.22–8.68 (ArH, m, 42H); 13C-NMR δ (ppm): 65.8 (C-3), 75.5 (C-4), 115.9–153.9 (aromatic carbon), 167.0 (CO β-lactam). Analysis calculated for C70H44N2O5: C, 84.66; H, 4.47; N, 2.82%. Found: C, 84.64; H, 4.48; N, 2.80%. 2-(Anthracen-9-yl)-1-(3-(4-(2-(anthracen-9-yl)-4-oxospiro[azetidine-3,9’-xanthene]-1-yl)phenoxy) phenyl)spiro[azetidine-3,9’-xanthen]-4-one (4d): Orange solid (Yield 85%); Mp: 140–142 °C; IR (KBr, cm−1): 1,759 (CO β-lactam); n class="Chemical">1H-NMR δ (ppm): 6.15 (H-4, s, 2H), 6.40–8.79 (ArH, m, 42H). 13C-NMR δ (ppm): 65.8 (C-3), 75.7 (C-4), 117.5–157.4 (aromatic carbon), 167.4 (CO β-lactam). Analysis calculated for C70H44N2O5: C, 84.66; H, 4.47; N, 2.82%. Found: C, 84.63; H, 4.45; N, 2.81%. 1,1’-(4,4’-Methylenebis(4,1-phenylene))bis(4-(anthracen-9-yl)-3-phenoxyazetidin-2-one) (4e): Yellow solid (Yield 80%); Mp: 146–148 °C; IR (KBr, cm−1): 1,755 (CO β-lactam); n class="Chemical">1H-NMR δ (ppm): 3.42 (CH2, s, 2H) 5.85 (H-4, d, 2H, J = 2.8), 6.40 (H-3, d, 2H, J = 2.8), 6.47–9.54 (ArH, m, 36H); 13C-NMR δ (ppm): 40.5 (CH2) 62.9 (C-3), 59.1 (C-4), 115.6–157.1 (aromatic carbon), 163.3 (CO β-lactam). Analysis calculated for C59H42N2O4: C, 84.06; H, 5.02; N, 3.32%. Found: C, 84.10; H, 5.08; N, 3.35%. 1,1’-(3,3’-Methylenebis(3,1-phenylene))bis(4-(anthracen-9-yl)-3-phenoxyazetidin-2-one) (4f): Orange solid (Yield 87%); Mp: 118–120 °C; IR (KBr, cm−1): 1,758 (CO β-lactam); n class="Chemical">1H-NMR δ (ppm): 3.47 (CH2, s, 2H) 5.71 (H-4, d, 2H, J = 3.6), 6.38 (H-3, d, 2H, J = 3.6), 6.41–9.41 (ArH, m, 36H); 13C-NMR δ (ppm): 41.1 (CH2) 82.6 (C-3), 60.6 (C-4), 115.5–157.1 (aromatic carbon), 163.4 (CO β-lactam); Analysis calculated for C59H42N2O4: C, 84.06; H, 5.02; N, 3.32%. Found: C, 84.08; H, 5.05; N, 3.30%. 1,1’-(4,4’-Oxybis(4,1-phenylene))bis(4-(anthracen-9-yl)-3-phenoxyazetidin-2-one) (4g): Orange solid (Yield 90%); Mp: 126–128 °C; IR (KBr, cm−1): 1,755 (CO β-lactam); n class="Chemical">1H-NMR δ (ppm): 5.71 (H-4, d, 2H, J = 5.1), 6.20 (H-3, d, 2H, J = 5.1), 6.36–8.78 (m, ArH, 36H);13C-NMR δ (ppm): 83.1 (C-3), 59.2 (C-4), 115.6–133.0 (aromatic carbon), 167.7 (CO β-lactam). Analysis calculated for C58H40N2O5: C, 82.45; H, 4.77; N, 3.32%. Found: C, 82.41; H, 4.79; N, 3.35%. 4-(Anthracen-9-yl)-1-(3-(4-(2-(anthracen-9-yl)-4-oxo-3-phenoxyazetidin-yl)phenoxy)phenyl)-3-phen oxyazetidin-2-one (4h): Yellow solid (Yield 95%); Mp: 118–120 °C; IR (KBr, cm−1): 1,758 (CO β-lactam); n class="Chemical">1H-NMR δ (ppm): 5.75 (H-4, d, 2H, J = 3.8), 6.25 (H-3, d, 2H, J = 3.8), 6.42–8.79 (ArH, m, 36H); 13C-NMR δ (ppm): 83.1 (C-3), 65.4 (C-4), 107.7–157.4 (aromatic carbon), 163.5 (CO β-lactam). Analysis calculated for C58H40N2O5: C, 82.45; H, 4.77; N, 3.32%. Found: C, 82.43; H, 4.75; N, 3.30%. 1,1’-(1,4-Phenylene)bis(4-(anthracen-9-yl)-3-phenoxyazetidin-2-one) (6a): Gray solid (Yield 96%); Mp: 178–180 °C (dec.); IR (KBr, cm−1): 1,751 (CO β-lactam); n class="Chemical">1H-NMR δ (ppm): 5.58 (H-4, d, 2H, J = 3.9), 6.30 (H-3, d, 2H, J = 3.9), 6.33–8.82 (ArH, m, 32H);13C-NMR δ (ppm): 83.0 (C-3), 59.1 (C-4), 114.6–156.8 (aromatic carbon), 163.0 (CO β-lactam). Analysis calculated for C52H36N2O4: C, 82.96; H, 4.82; N, 3.72% Found: C, 82.95; H, 4.81; N, 3.70%. 1,1’-(1,4-Phenylene)bis(2-(anthracen-9-yl)spiro[azetidine-3,9’-xanthen]-4-one) (6b): Orange solid (Yield 85%); Mp: 186–188 °C (dec.); IR (KBr, cm−1): 1,751 (CO β-lactam); 1H-NMR δ (ppm): 6.27 (H-4, s, n class="Chemical">2H), 6.30–8.99 (ArH, m, 38H); 13C-NMR δ (ppm): 59.7 (C-3), 75.2 (C-4), 115.9–152.0 (aromatic carbon), 167.0 (CO β-lactam). Analysis calculated for C64H40N2O4: C, 85.31; H, 4.47; N, 3.11%. Found: C, 85.30; H, 4.45; N, 3.15%.

4. Conclusions

This article describes for the first time the synthesis and chn class="Chemical">aracterization of some examples of mono-and bis-spiro- and nonspiro-β-lactams bearing a polycyclic aromatic moiety by reaction of polycyclic aromatic imines and two ketenes derived from 9H-xanthene-9-carboxylic acid and phenoxyacetic acid. These ketenes were prepared in situ with triethylamine and p-toluenesulfonyl chloride.
  30 in total

Review 1.  Asymmetric synthesis of beta-lactams through the Staudinger reaction and their use as building blocks of natural and nonnatural products.

Authors:  C Palomo; J M Aizpurua; I Ganboa; M Oiarbide
Journal:  Curr Med Chem       Date:  2004-07       Impact factor: 4.530

2.  Pd-Cu bimetallic catalyzed domino cyclization of alpha-allenols followed by a coupling reaction: new sequence leading to functionalized spirolactams.

Authors:  Benito Alcaide; Pedro Almendros; Raquel Rodríguez-Acebes
Journal:  Chemistry       Date:  2005-09-19       Impact factor: 5.236

3.  Azabicyclic amino acids by stereoselective dearomatizing cyclization of the enolates of N-nicotinoyl glycine derivatives.

Authors:  Gareth Arnott; Jonathan Clayden; Stuart D Hamilton
Journal:  Org Lett       Date:  2006-11-09       Impact factor: 6.005

4.  4-(9-Anthr-yl)-1-(2,4-dimethoxy-phen-yl)spiro-[azetidine-3,9'-xanthen]-2-one.

Authors:  Zeliha Baktır; Mehmet Akkurt; Aliasghar Jarrahpour; Edris Ebrahimi; Orhan Büyükgüngör
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-06-20

Review 5.  Azetidin-2-ones, synthon for biologically important compounds.

Authors:  A R A S Deshmukh; B M Bhawal; D Krishnaswamy; Vidyesh V Govande; Bidhan A Shinkre; A Jayanthi
Journal:  Curr Med Chem       Date:  2004-07       Impact factor: 4.530

6.  Synthesis of novel N-sulfonyl monocyclic beta-lactams as potential antibacterial agents.

Authors:  Aliasghar Jarrahpour; Maaroof Zarei
Journal:  Molecules       Date:  2006-01-31       Impact factor: 4.411

7.  Azetidin-2-one derivatives as inhibitors of thrombin.

Authors:  W T Han; A K Trehan; J J Wright; M E Federici; S M Seiler; N A Meanwell
Journal:  Bioorg Med Chem       Date:  1995-08       Impact factor: 3.641

8.  Efficient entry to diversely functionalized spirocyclic oxindoles from isatins through carbonyl-addition/cyclization reaction sequences.

Authors:  Benito Alcaide; Pedro Almendros; Raquel Rodríguez-Acebes
Journal:  J Org Chem       Date:  2006-03-17       Impact factor: 4.354

9.  Penicillin-bound polyacrylate nanoparticles: restoring the activity of beta-lactam antibiotics against MRSA.

Authors:  Edward Turos; G Suresh Kumar Reddy; Kerriann Greenhalgh; Praveen Ramaraju; Sampath C Abeylath; Seyoung Jang; Sonja Dickey; Daniel V Lim
Journal:  Bioorg Med Chem Lett       Date:  2007-03-27       Impact factor: 2.823

10.  Novel N-thiolated beta-lactam antibiotics selectively induce apoptosis in human tumor and transformed, but not normal or nontransformed, cells.

Authors:  Aslamuzzaman Kazi; Randy Hill; Timothy E Long; Deborah J Kuhn; Edward Turos; Q Ping Dou
Journal:  Biochem Pharmacol       Date:  2004-01-15       Impact factor: 5.858

View more
  3 in total

1.  3-(2,4-Dichloro-phen-oxy)-1-(4-meth-oxy-phen-yl)-4-(3-nitro-phen-yl)azetidin-2-one.

Authors:  Mehmet Akkurt; Sevim Türktekin; Aliasghar Jarrahpour; Seid Ali Torabi Badrabady; Orhan Büyükgüngör
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-12-18

2.  Crystal structure of 2-[(3S,4S)-4-(anthracen-9-yl)-1-(4-meth-oxy-phen-yl)-2-oxoazetidin-3-yl]-2-aza-2H-phenalene-1,3-dione unknown solvate.

Authors:  Ísmail Çelik; Mehmet Akkurt; Aliasghar Jarrahpour; Javad Ameri Rad; Ömer Çelik
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-02-13

3.  1-(Morpholin-4-yl)-4-(2-nitro-phen-yl)spiro-[azetidine-3,9'-xanthen]-2-one.

Authors:  Zeliha Atioğlu; Mehmet Akkurt; Aliasghar Jarrahpour; Roghayeh Heiran; Namık Ozdemir
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.